Senior representatives of CSL appeared earlier this week before the ongoing Senate inquiry into the federal government's response to the COVID-19 pandemic.
-
Latest News CSL: 'We have well over one million doses in the fridge' March 4, 2021
-
Latest News Research identifies cause and potential treatment for COVID-19-induced heart damage March 4, 2021Researchers at the Brisbane-based QIMR Berghofer have discovered some of the ways COVID-19 damages the heart and identified a class of drugs that could potentially protect or reverse this injury.
-
Othocell confirms Australian reimbursement for CelGro March 4, 2021Regenerative medicine company Orthocell (ASX:OCC) has announced it has received notification from the Australian Department of Health that its CelGro Dental has been included on the Prostheses List.
-
Latest News Osprey expands US sales coverage with new sales agency agreements March 2, 2021Osprey Medical (ASX:OSP) has signed Independent Sales Agency agreements with Access Medical, Consolidated Medical Supplies and DriKot Medical that will expand its sales coverage in the US.
-
AusBiotech Funding opens for advanced bio-manufacturing March 2, 2021AusBiotech welcomes the Government’s support of the biotech industry as it opens the first round of funding for bio-manufacturing and launches its Medical Products’ National Manufacturing Priority road map.
-
Latest News Botanix expands its management team March 2, 2021Australian clinical-stage synthetic cannabinoid company Botanix Pharmaceuticals (ASX:BOT) has announced the expansion of its management team with the appointment of three executives in the US.
-
Latest News Cynata Therapeutics announces new study of cell therapy March 2, 2021Cynata Therapeutics (ASX:CYP), a clinical-stage biotechnology company specialising in cell therapeutics, has announced the initiation of a new study to investigate its Cymerus mesenchymal stem cells.
-
Latest News Funding for advances in medical research technology March 2, 2021Health minister Greg Hunt has announced the federal government will invest $100 million in the development of new technologies to improve diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19.
-
Latest News Opthea confirms plans and protocols for late-stage OPT-302 studies February 25, 2021Opthea (ASX:OPT) says it has finalised the protocol study designs and key start-up activities in readiness for the initiation of the phase three ShORe and COAST pivotal clinical trials of OPT-302 in wet age-related macular degeneration.
-
AusBiotech Feedback sought on gene technology changes February 25, 2021AusBiotech is seeking feedback from members on proposed changes to the Gene Technology Scheme (the Scheme) that may impact companies and early research working with GMOs.
-
Latest News FDA approval for new Cochlear sound processor February 25, 2021Cochlear, a global leader in implantable hearing solutions, has received US FDA clearance and CE Mark accreditation for the Baha 6 Max Sound Processor.
-
Latest News CSIRO secures licence to develop medicinal cannabis February 25, 2021CSIRO has announced plans to develop new medicinal cannabis products designed to assist people with a variety of conditions including multiple sclerosis and chronic pain.
-
Latest News Telix Pharmaceuticals secures clearance for Japanese trial February 25, 2021Telix Pharmaceuticals (ASX.TLX) has announced that its Japanese subsidiary and partner Kanazawa University have received Clinical Trial Notification clearance to commence a phase one trial of its prostate cancer imaging product TLX591-CDx.
New Stories
-
Othocell confirms Australian reimbursement for CelGro
March 4, 2021 - -
Kazia Therapeutics signs global agreement for lead candidate
March 4, 2021 - - Latest News -
CSL: 'We have well over one million doses in the fridge'
March 4, 2021 - - Latest News -
Mesoblast boosts cash through private placement
March 4, 2021 - - Latest News -
Research identifies cause and potential treatment for COVID-19-induced heart damage
March 4, 2021 - - Latest News -
AusMedtech 2021 programme launched
March 4, 2021 - - AusBiotech -
Osprey expands US sales coverage with new sales agency agreements
March 2, 2021 - - Latest News